Medical Properties Trust, Inc.
NYSE:MPTREIT - Healthcare Facilities
-$0.02 today
- Market cap
- $959.91M
- Beta
- 1.46
- P/E (TTM)
- -22.0
- EPS (TTM)
- -$0.21
- Dividend yield
- 7.55%
Volume 29.38M
Average 5.52M
MPT Depreciation & Amortization
Non-cash asset write-downs added back to net income because no cash left the business.
Medical Properties Trust, Inc.NYSE: MPT
Depreciation & Amortization · Q2 FY2026 · quarter ended Jun 2026
Depreciation & amortization growth accelerates
Q2 FY2026 depreciation & amortization of $86.02M rose 26.1% year over year, ahead of the -27.4% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 23.4% from the prior quarter. Over 3 fiscal years it compounded at -7.6% a year.
Context
- Depreciation & amortization amounted to 28.1% of revenue in FY2025, down 17.5 pp from a year earlier.
- Depreciation & amortization increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +26.1% holds above the trailing-twelve-month pace of -27.4%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the cash flow
- Latest · FY2025
- 272.82M USD
- Year-over-year change
- -39.9%
- 4-year CAGR
- -4.9%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 272.82M | -39.9% |
| FY2024 | 2024-12-31 | 453.75M | -26.4% |
| FY2023 | 2023-12-31 | 616.13M | +78.3% |
| FY2022 | 2022-12-31 | 345.58M | +3.5% |
| FY2021 | 2021-12-31 | 333.78M | — |
Depreciation & Amortization vs competitors
How MPT compares with its peers on the latest reported figures
- MPT's LTM Jun 2026 depreciation & amortization of $294.89M is the 7th largest of the 9 companies compared; the peer median is $443.37M.
- Its year-over-year change of -27.4% is the lowest of 9, against a peer median of +5.6%.
- Depreciation & amortization amounts to 28.9% of revenue for MPT, versus a peer median of 27.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $2.56B | +2.5% | +14.8% | 42.0% | |
| LTM Sep 2026 | $1.09B | +1.8% | +12.9% | 48.6% | |
| LTM Jun 2026 | $1.04B | +3.9% | +12.3% | 13.7% | |
| LTM Jun 2026 | $555.9M | +6.5% | -1.5% | 29.3% | |
| LTM Jun 2026 | $330.85M | +4.6% | -0.7% | 25.6% | |
| LTM Sep 2026 | $318.21M | +7.2% | +3.2% | 35.3% | |
MPTMedical Properties Trust, Inc. | LTM Jun 2026 | $294.89M | -27.4% | -7.6% | 28.9% |
| LTM Jun 2026 | $209.43M | +21.7% | -0.1% | 24.4% | |
| LTM Sep 2026 | $49.02M | +35.7% | +0.3% | 12.4% | |
| Peer median (excluding MPT) | $443.37M | +5.6% | +1.8% | 27.5% | |
Competitors are the stored peer set for MPT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 656.94M | 903.82M | (556.09M) | (2.41B) | (275.94M) |
| Depreciation & Amortization | 333.78M | 345.58M | 616.13M | 453.75M | 272.82M |
| Deferred Income Tax | 42.75M | 10.7M | (167.33M) | 5.12M | (11.23M) |
| Stock-Based Compensation | 52.11M | 49.42M | 33.25M | 32.98M | 25.75M |
| Change in Working Capital | 13.12M | 29.59M | 16.72M | (15.6M) | 34.15M |
| Accounts Receivables | (23.87M) | (116.42M) | (141.73M) | 2.78M | 7.11M |
| Inventory | 23.87M | 116.42M | 0 | 0 | 0 |
| Accounts Payables | 54.06M | 33.58M | 0 | 0 | 0 |
| Other Working Capital | (40.94M) | (3.99M) | 158.45M | (18.38M) | 27.04M |
| Other Non-Cash Items | (287.04M) | (600.09M) | 563.12M | 2.18B | 185.22M |
| Operating Cash Flow | 811.66M | 739.01M | 505.79M | 245.48M | 230.77M |
| Capital Expenditures | (65.55M) | (1.54B) | 0 | 0 | 0 |
| Acquisitions (Net) | (5.28B) | (1.32B) | (222.76M) | (93.96M) | (142.09M) |
| Purchases of Investments | (289.24M) | (207.39M) | (294.17M) | (156.08M) | (73.75M) |
| Sales of Investments | 65.55M | 14.3M | 0 | 0 | 0 |
| Other Investing Activities | 1.72B | 3.45B | 1.03B | 1.57B | (48.9M) |
| Investing Cash Flow | (3.86B) | 396.06M | 517.56M | 1.32B | (264.74M) |
| Debt Repayment | 2.58B | (537.49M) | (420.25M) | 102.38M | 501.77M |
| Common Stock Issued | 1.05B | 0 | 0 | (3.81M) | (2.47M) |
| Common Stock Repurchased | 0 | (17.94M) | (8.08M) | 0 | (23.44M) |
| Dividends Paid | (643.47M) | (698.54M) | (615.39M) | (321.08M) | (193.26M) |
| Other Financing Activities | (36.67M) | (88.55M) | 23.39M | (1.26B) | (54.51M) |
| Financing Cash Flow | 2.95B | (1.34B) | (1.02B) | (1.48B) | 228.08M |
| Effect of Forex Changes | 4.66M | (12.89M) | 11.4M | (5.22M) | 14.71M |
| Net Change in Cash | (94.49M) | (220.34M) | 14.41M | 79.22M | 208.82M |
| Free Cash Flow | 746.11M | (801.35M) | 505.79M | 245.48M | 230.77M |
Medical Properties Trust, Inc.
NYSE:MPT
Intrinsic Alpha fair value
Locked
Current Price
$1.63
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.